63. The Early Outcome of Lung Transplantation with the Lung Allografts from the Donors Tested Positive for COVID-19

Jules Lin, M.D. is a Professor in the Section of Thoracic Surgery at the University of Michigan and the Mark B. Orringer Research Professor. He is the Associate Chief Clinical Officer, CV/Neuro. He is involved in establishing national guidelines as a member of the National Comprehensive Cancer Network (NCCN) Non-Small Cell Lung Cancer, Mesothelioma, and Thymoma Guideline Panels, is the Chair and Section Editor for the Society of Thoracic Surgeons, Curriculum Task Force, and is a Features Editor for the Journal of Thoracic and Cardiovascular Surgery. He specializes in general thoracic surgery and has an interest in minimally invasive approaches in the treatment of lung and esophageal diseases as well as lung transplantation. His research interests include investigating the molecular biology of esophageal carcinoma and mechanisms behind chemoresistance. He is also evaluating the use of morphomic analysis of CT scans to identify differences in body composition associated with frailty and whether these morphomic factors can predict outcomes after thoracic surgery. 

Dr. Harano is a thoracic surgeon at Division of General Thoracic Surgery, Keck School of Medicine, University of Southern California. He graduated from Kumamoto University School of Medicine and was trained at Toranomon Hospital in Tokyo, Japan and Brigham and Women’s Hospital in Boston. Subsequently he completed cardiothoracic transpalnt fellowship at Universuty of Pittsburgh Medical Center. His clinical interests focus on minimally invasive thoracic surgery and lung transplantation. He is board-certified by the Japanese Association for Chest Surgery.